Nov 24 (Reuters) - Lexagene Holdings Inc LXG.V :
* LEXAGENE INTENDS TO PURSUE FULL PANEL PATHOGEN TESTING THROUGH THE FDA
Source text for Eikon: ID:nGNX1YmwW9 Further company coverage: LXG.V
((Reuters.Briefs@thomsonreuters.com;))
BRIEF-Lexagene Intends To Pursue Full Panel Pathogen Testing Through The FDA
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.